Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Freshworks stock price target raised by Wolfe Research on improving fundamentals

EditorEmilio Ghigini
Published 20/02/2024, 07:48 pm
Updated 20/02/2024, 07:48 pm
© Reuters.

Tuesday, Wolfe Research raised its rating on Freshworks Inc (NASDAQ:FRSH) from Peerperform to Outperform and set a new price target of $27.00. The firm highlighted a shift in the company's prospects, citing improved fundamentals and execution, as well as competitive dynamics that could support a multi-year revenue growth of 20% with expanding margins.

The upgrade comes after Wolfe Research had previously downgraded Freshworks in December 2022 due to a challenging macroeconomic environment, post-IPO execution challenges, and declining revenue growth. However, the analyst now sees a "very different setup," with the last three quarters showing a stabilized macro environment, improved customer retention, and positive sales leadership changes that could lead to accelerated growth and double-digit operating margins.

The firm's Tactical Analysis indicates that Freshworks is trading at a 24% discount to the median of its peer group based on calendar year 2025 revenue projections. Additionally, the stock is at a nearly 38% discount on Wolfe Research's relative valuation chart and holds the highest discount to competitor HubSpot (NYSE:HUBS) since August, at 41%. The analyst believes these discounts are unwarranted given the company's competitive position.

Freshworks' competitive edge is also seen in its increasing win rates against legacy competitors and the inclusion of Freddy AI in many contracts, which is expected to lower adoption friction and open opportunities for monetization upon renewals. The firm's upside model predicts accelerating top-line growth in 2024 and beyond, with a 20%+ growth through 2026, alongside continued margin leverage.

Despite mixed demand trends in the SMB segment, Wolfe Research is optimistic about the mid-market adoption of GenAI functionality and views Freshworks' significant non-US revenue as a strategic advantage compared to peers. The firm anticipates that earnings will be the primary catalyst for the stock's performance, with potential positive momentum during the upcoming conference season as investors recognize the value in Freshworks' stock. The new price target of $27.00 implies a 9x multiple of calendar year 2025 estimated sales.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.